Creatinine- and Cystatin C-Based Incidence of Chronic Kidney Disease and Acute Kidney Disease in AKI Survivors
Background. Renal dysfunction after acute kidney injury (AKI) is common, potentially modifiable, but poorly understood. Acute kidney disease (AKD) describes renal dysfunction 7 to 90 days after AKI and is determined by percentage change in creatinine from baseline. Chronic kidney disease (CKD) is de...
Saved in:
Main Authors: | Claire Rimes-Stigare, Bo Ravn, Akil Awad, Klara Torlén, Claes-Roland Martling, Matteo Bottai, Johan Mårtensson, Max Bell |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Critical Care Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2018/7698090 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serum Cystatin C, Markers of Chronic Kidney Disease, and Retinopathy in Persons with Diabetes
by: Chee Wai Wong, et al.
Published: (2015-01-01) -
Determination of Cystatin C Level in a Sample of Patients with Chronic Kidney Disease
by: Maryam Noman Salman, et al.
Published: (2022-11-01) -
Biomarker Acute Kidney Injury (AKI) pada Sepsis
by: Dional Setiawan, et al.
Published: (2018-07-01) -
Creatinine-Based Estimations of Kidney Function Are Unreliable in Obese Kidney Donors
by: Nidhi Aggarwal, et al.
Published: (2012-01-01) -
Cystatin C as a Predictor of Mortality and Cardiovascular Events in a Population with Chronic Kidney Disease
by: Ana Vigil, et al.
Published: (2014-01-01)